nach oben

2015 | OriginalPaper | Buchkapitel

23. Entzündliche Lebererkrankungen

Autoren: Dr. med. Anita Pathil-Warth, Prof. Dr. med. Wolfgang Stremmel, Prof. Dr. med. Thomas Berg, Dr. med. Julia Benckert, PD Dr. med. Johannes Wiegand, Dr. med. Mathias Pfersdorff, Prof. Dr. med. Michael Kraus, PD Dr. med. Matthias Banasch, Prof. Dr. med. Wolfgang E. Schmidt, Prof. Dr. med. Hermann Wasmuth, Prof. Dr. med. Christian Trautwein

Verlag: Springer Berlin Heidelberg

Erschienen in: Viszeralmedizin

» Jetzt Zugang zum Volltext erhalten

Zusammenfassung

Autoren

Gastroenterologie: A. Pathil-Warth, W. Stremmel

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

b.Flat Gastrointestinale Chirurgie

Das Paket für alle Viszeral- und Allgemeinchirurgen, die ihren Schwerpunkt in der gastrointestinalen Chirurgie haben und sich für die ganze Breite des Bereichs interessieren. Das Abo beinhaltet:

Onlinezugriff auf die Inhalte von 9 Springer Chirurgie-Fachbüchern
Immer die neueste Auflagen
Volltextsuche, Lesezeichen und offline lesen

Jetzt informieren

b.Flat Viszeral- und Allgemeinchirurgie 360°

Das umfangreiche Paket für alle Viszeral- und Allgemeinchirurgen, die sich für die ganze Breite der beiden Fachgebiete und auch für Spezialthemen interessieren. Das Abo beinhaltet:

Onlinezugriff auf die Inhalte von 16 Springer Chirurgie-Fachbüchern
Immer die neueste Auflagen
Volltextsuche, Lesezeichen und offline lesen

Jetzt informieren

Friedman SL (2003) Liver fibrosis – from bench to bedside. J Hepatol 38(Suppl. 1):38–53 CrossRef

Friedman SL (2004) Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1(2):98–105 CrossRefPubMed

Gabele E, Brenner DA, Rippe RA (2003) Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 8:D69–D77 CrossRefPubMed

Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539–548 PubMedCentralCrossRefPubMed

Parsons CJ, Takashima M, Rippe RA (2007) Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 22(Suppl. 1):79–84 CrossRef

Sandrin L et al (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713 CrossRefPubMed

Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2):199–210 PubMedCentralCrossRefPubMed

Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC) (2007) Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP. MMWR Morb Mortal Wkly Rep 56:1080–1084

Aggarwal R (2013a) Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 10:24–33 CrossRefPubMed

Aggarwal R (2013bb) Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin Liver Dis 33:30–40 (Erratum in: Semin Liver Dis 2013; 33: 185) CrossRefPubMed

Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, Salmon D (2014) Hepatitis E: An emerging infection in high income countries. J Clin Virol 59:81–88 CrossRefPubMed

Baechlein C, Schielke A, Johne R, Ulrich RG, Baumgaertner W, Grummer B (2010) Prevalence of Hepatitis E virus-specific antibodies in sera of German domestic pigs estimated by using different assays. Vet Microbiol 144(1–2):187–191 CrossRefPubMed

Benckert J, Berg T (2011) Diagnostik und Klinik der Infektion mit Hepatitis-A- und Hepatitis-E-Viren. Übertragung durch Trinkwasser und Lebensmittel. Pharm Unserer Zeit 40:25–29 CrossRefPubMed

Berg T, Marcellin P, Zoulim F, Moller B, Trinh H, Chan S et al (2010) Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology 139(4):1207–1217 CrossRefPubMed

Böhlig A, Berg T (2013) Impfung bei Virushepatitis. Der Gastroenterologe 8:41–49 CrossRef

van Bömmel F, Berg T (2014) Antiviral therapy of chronic hepatitis B. Intervirology 57(3–4):171–180 CrossRefPubMed

van Bömmel F, Wiegand J, Berg T (2014) Standard of care for hepatitis B virus infection. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H (Hrsg) Hepatology Clinical Textbook, 5. Aufl. Flying Publisher, S 140–170 ( www.hepatologytextbook.com (free pdf download))

Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B et al (2010) Use of HBsAg serum levels help to distinguish active from inactive HBV genotype D carriers. Gastroenterology 139(2):483–490 CrossRefPubMed

Chau TN, Lai ST, Tse C, Ng TK, Leung VK, Lim W, Ng MH (2006) Epidemiology and Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 198 clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 101:292–296 CrossRefPubMed

Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T et al (2007) Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011. Z Gastroenterol 45(6):525–574 CrossRefPubMed

Dalton HR, Hunter JG, Bendall R (2013a) Autochthonous hepatitis E in developed countries and HEV/HIV coinfection. Semin Liver Dis 33:50–61 CrossRefPubMed

Dalton HR, Hunter JG, Bendall RP (2013b) Hepatitis E. Curr Opin Infect Dis 26:471–478 PubMed

Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC) (2009) Surveillance for acute viral hepatitis – United States, 2007. MMWR Surveill Summ 58:1–27 PubMed

European Association For The Study Of The Liver (2009) EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol 50(2):227–242 CrossRef

Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358:811–817 CrossRefPubMed

Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, Alric L, Peron JM, Izopet J (2010) Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 139(5):1612–1618 CrossRefPubMed

Koff RS (1992) Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 10(Suppl 1):15–17 CrossRef

Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC et al (2008) Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134(5):1376–1384 CrossRefPubMed

Lemon SM (1997) Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem 43:1494–1499 PubMed

Manns PM, Wedemeyer H, Wiegand J (2009) Handbuch Hepatitis C: Diagnostik, Verlauf, Therapie, 3. Aufl. Uni-Med

Mariño Z, van Bömmel F, Forns X, Berg T (2014) New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C. Gut 63:207–215 PubMed

Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H (Hrsg) (2014) Hepatology Clinical Textbook, 5. Aufl. Flying Publisher, ( www.hepatologytextbook.com (free pdf download))

Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M et al (2009) Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 49(4):1151–1157 CrossRefPubMed

Puchner KP, Berg T (2010) Hepatitis C: Extrahepatic manifestations. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H (Hrsg) Hepatology Clinical Textbook, 5. Aufl. Flying Publisher, S 307–320

Raimondi S, Maisonneuve P, Bruno S, Mondelli MU (2010) Is response to antiviral treatment influenced by hepatitis B virus genotype? J Hepatol 52(3):441–449 CrossRefPubMed

Rizzetto M (2009) Hepatitis D: thirty years after. J Hepatol 50:1043–1050 CrossRefPubMed

RKI (2008) Zur Situation der Hepatitis A in Deutschland im Jahr 2007. Epidemiologisches Bulletin 44:379–384

Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M (2009) A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136:1629–1638 CrossRefPubMed

Schiff ER (1992) Atypical clinical manifestations of hepatitis A. Vaccine 10(Suppl 1):18–20 CrossRef

Van der Poel WH (2014) Food and environmental routes of Hepatitis E virus transmission. Curr Opin Virol 4:91–96 CrossRefPubMed

Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP (2007) Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357:1685–1694 CrossRefPubMed

Wedemeyer H, Manns MP (2010) Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 7:31–40 CrossRefPubMed

Wiegand J, Hasenclever D, Tillmann HL (2008) Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther 13(2):211–220 PubMed

Wiegand J, Van Bömmel F, Berg T (2010) Management of chronic hepatitis B: status and challenges beyond treatment guidelines. Semin Liver Dis 30(4):361–377 CrossRefPubMed

Wedemeyer H et al (2011) Peginterferon plus Adefovir versus either drug alon for hepatitis Delta. N Engl J Med 364:322–331 CrossRefPubMed

Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind placebo-controlled trial. Gastroenterology 119:1637–1648 CrossRefPubMed

Lucey MR, Mathurin P, Morgan TR (2009) Medical progress. Alcoholic hepatitis. N Eng J Med 360:2758–2769 CrossRef

Mathurin P, O’Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR (2011) Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 60:255–260 CrossRefPubMed

O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) AASLD Practice Guidelines. Alcoholic Liver Disease. Hepatology 51(1):307–328 CrossRefPubMed

Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C (2008) Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 27:1167–1178 CrossRefPubMed

Stickel F, Hoehn B, Schuppan D, Seitz HK (2003) Review article: nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 18:357–373 CrossRefPubMed

Sanyal AJ (2008) Fatty liver disease. Semin Liver Dis 28(4):337 CrossRefPubMed

Al-Chalabi T, Boccato S, Portmann BC et al (2006) Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH follone at a tertiary referral centre. J Hepatol 45:575–583 CrossRefPubMed

Czaja AJ (2009) Autoimmune liver disease. Curr Opin Gastroenterol 25:215–222 CrossRefPubMed

Hennes EM, Zeniya M, Czaja AJ et al (2008) International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176 CrossRefPubMed

Krawitt EL (2006) Autoimmune hepatitis. New Engl J Med 354:54–66 CrossRefPubMed

Montano-Loza AJ, Carpenter HA, Czaja AJ (2007) Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 102:1005–1012 CrossRefPubMed

Teufel A, Galle PR, Kanzler S (2009) Update on autoimmune hepatitis. World J Gastroenterol 15:1035–1041 PubMedCentralCrossRefPubMed

Wiegard C, Schramm C, Lohse AW (2009) Scoring systems fort he diagnosis of autoimmune hepatitis: past, present, and future. Semi Liver Dis 29:254–261 CrossRef

Yeoman AD, Al-Chalabi T, Karani JB et al (2008) Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 48:863–870 CrossRefPubMed

Arroyo V, Colmenero J (2003) Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 38:S69–S89 CrossRefPubMed

Bosch J, Garcia-Pagan JC (2003) Prevention of variceal rebleeding. Lancet 361:952–954 CrossRefPubMed

Ferenci P, Lockwood A, Mullen K, Tarter A, Weissenborn K, Blei AT, Members of the Working Party (2002) Hepatic Encephalolopathy – Definition, Nomenclature, Diagnosis, and Quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3):716–721 CrossRefPubMed

Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655–1669 PubMedCentralCrossRefPubMed

Garcia-Tsao G, Bosch J (2010) Management of varices and variceal hemorrhage in cirrhosis. N Eng J Med 362:823–832 CrossRef

Prakash R, Mullen K (2010) Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 7:515–525 CrossRefPubMed

Rodriguez-Roisin R, Krowka MJ (2008) Hepatopulmonary syndrome – a liver-induced lung vascular disorder. N Eng J Med 358:2378–2387 CrossRef

Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310–1318 PubMedCentralPubMed

Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–851 PubMedCentralCrossRefPubMed

Stauber RE, Olschewski H (2010) Portopulmonary hypertension: short review. Eur J Gastroenterol Hepatol 22:385–390 CrossRefPubMed

Tripathi D, Hayes PC (2010) The role of carvedilol in the management of portal hypertension. Eur J Gastroenterol Hepatol 22:905–911 CrossRefPubMed

Titel

Entzündliche Lebererkrankungen

Buch

Viszeralmedizin

Print ISBN: 978-3-642-14300-7

Electronic ISBN: 978-3-642-14301-4

https://doi.org/10.1007/978-3-642-14301-4

DOI

https://doi.org/10.1007/978-3-642-14301-4_23

Autoren:

Dr. med. Anita Pathil-Warth
Prof. Dr. med. Wolfgang Stremmel
Prof. Dr. med. Thomas Berg
Dr. med. Julia Benckert
PD Dr. med. Johannes Wiegand
Dr. med. Mathias Pfersdorff
Prof. Dr. med. Michael Kraus
PD Dr. med. Matthias Banasch
Prof. Dr. med. Wolfgang E. Schmidt
Prof. Dr. med. Hermann Wasmuth
Prof. Dr. med. Christian Trautwein

Verlag

Springer Berlin Heidelberg

Sequenznummer

Kapitelnummer

Neu im Fachgebiet Innere Medizin

01.03.2021 | Thorakale und kardiale Radiologie | Nachrichten

Newsletter bestellen

Bildnachweise

Mail Icon II

Springer Medizin

23. Entzündliche Lebererkrankungen

Zusammenfassung

Autoren

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

b.Flat Gastrointestinale Chirurgie

b.Flat Viszeral- und Allgemeinchirurgie 360°

Neu im Fachgebiet Innere Medizin

CT-Schema zur Emphysemprognose von Rauchern

So gefährlich sind schwere COVID-19-Verläufe in der Schwangerschaft!

EKG-Pflaster deckt asymptomatisches Vorhofflimmern auf

Verdächtiger Mammografie-Befund? Covid-19-Impfung!

Newsletter